Controlling Drug Costs for People Living with HIV/AIDS: Federal Regulation of Pharmaceutical Prices in Canada

Controlling Drug Costs for People Living with HIV/AIDS: Federal Regulation of Pharmaceutical Prices in Canada
The paper:

  • highlights the significance of policy on pharmaceutical pricing, given increasing costs and spending on medicines as part of overall healthcare spending in Canada;
  • identifies recent developments that are important because they inform current debates in Canada over regulating drug prices, or our policies in general relating to pharmaceuticals;
  • outlines current federal law and policy on the regulation of pharmaceutical manufacturers’ prices; and, finally,
  • makes recommendations for reform of federal regulation of pharmaceutical prices in Canada.


This entry was posted in English, French, Publications, Reports. Publication Topics: . Bookmark the permalink. Both comments and trackbacks are currently closed.
Author
Topics
Doc Type
Language